6+ mon, 1+ week ago   (342+ words) Avisi Technologies, Inc. announced it has secured $10.7 million in a recent Series A financing round to support the SAPPHIRE pivotal clinical trial evaluating its novel glaucoma treatment device: the VisiPlate. How: Via a microchannel network that controls aqueous drainage from…...

7+ mon, 2+ day ago   (252+ words) Global ophthalmic company Arctic Vision Limited announced plans to purchase the ophthalmic device business of MDCO Technology, a China-based ophthalmic medical device company. Also headquartered in China, the privately-held Arctic Vision is developing a portfolio of pre-clinical and commercial-stage ophthalmic…...

7+ mon, 1+ week ago   (395+ words) Newly renamed CSI Dry Eye Innovations has kicked off 2026 with an updated corporate brand and a newly-issued patent for its flagship dry eye disease (DED)-focused technology. Founded in 2019, the Canadian-based software company is best known as the developer and…...

8+ mon, 14+ hour ago   (358+ words) Nanodropper is kicking off the new year with a new corporate identity as Mu Medical and expansion into a precision eyecare platform with two other companies: Bedo Solutions and Viseon Labs. The new entity is formally debuting this week during…...

8+ mon, 14+ hour ago   (358+ words) Nanodropper is kicking off the new year with a new corporate identity as Mu Medical and expansion into a precision eyecare platform with two other companies: Bedo Solutions and Viseon Labs. The new entity is formally debuting this week during…...

8+ mon, 5+ day ago   (174+ words) Allotex Inc., a commercial-stage ophthalmic company with active European market adoption, announced that the U.S. Food and Drug Administration (FDA) has conditionally approved its Investigational Device Exemption (IDE), authorizing the initiation of a U.S. clinical study for ALLO-1™, its proprietary tissue-based solution…...